Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and ...
Capricor Therapeutics (NASDAQ:CAPR – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research ...
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research ...
H.C. Wainwright lowered the firm’s price target on Assertio Holdings (ASRT) to $3.50 from $4 and keeps a Buy rating on the shares following the ...
Whales with a lot of money to spend have taken a noticeably bullish stance on Archer Aviation. Looking at options history for Archer Aviation ACHR we detected 8 trades. If we consider the specifics of ...
Whatever is good for CoreWeave is probably good for Core Scientific, but the IPO might not be the most important recent ...
Kurt Gustafson; Chief Financial Officer, Executive Vice President - Finance; OmniAb Inc. Matthew Foehr; President, Chief Executive Officer, Director; OmniAb Inc. Joe ...
To list the 12 Most Shorted Stocks in 2025, we used a screener and shortlisted the most shorted stocks. Next, we mentioned ...
Plug Power (PLUG) announced the pricing of its underwritten registered offering of 46,500,000 shares of its common stock and in lieu of common ...
Oppenheimer & Co. Inc. is acting as the sole book-running manager for the offering. Roth Capital Partners, LLC, Craig-Hallum ...
We recently published a list of 12 Best Bitcoin Stocks To Buy According To Billionaires. In this article, we are going to ...
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results